Subtopic Deep Dive

Redox Signaling in Cancer Cells
Research Guide

What is Redox Signaling in Cancer Cells?

Redox signaling in cancer cells refers to the regulation of cellular signaling pathways by reactive oxygen species (ROS) and redox reactions that control proliferation, apoptosis, and metastasis in tumors.

Researchers examine how ROS modulate redox-sensitive proteins and thiol modifications to drive tumor progression (Varughese, 2014). Cytochrome c phosphorylation at serine 47 influences respiration and apoptosis in cancer contexts. Over 250M papers in PapersFlow enable discovery of related works like thymoquinone effects on ovarian carcinoma (Özdemır et al., 2023).

Curated Papers

Key Challenges

Why It Matters

Redox signaling insights guide therapies targeting oxidative stress to kill cancer cells selectively, as seen in thymoquinone reducing OVCAR-3 viability via ROS modulation (Özdemır et al., 2023). Cytochrome c regulation affects apoptosis resistance in tumors (Varughese, 2014). Warburg effect studies link redox metabolism to tumorigenesis, informing metabolic inhibitors (Peddapalli, 2025).

Key Research Challenges

Quantifying ROS in vivo

Direct measurement of ROS levels in tumors remains difficult due to their short half-life and tissue heterogeneity. Techniques like X-ray diffraction aid structural insights but struggle with dynamic redox states (Iqtadar et al., 2023). In vitro models like OVCAR-3 provide proxies but lack tumor microenvironment fidelity (Özdemır et al., 2023).

Deciphering redox protein modifications

Thiol modifications on proteins like cytochrome c require precise characterization amid multiple phosphorylation sites. Serine 47 phosphorylation alters cytochrome c function in apoptosis, but interplay with redox changes is unclear (Varughese, 2014). Metal ion roles in redox enzymes add complexity (Rosenzweig, 2013).

Translating to selective therapies

Modulating redox signaling risks normal cell toxicity, as cancer cells adapt via resistance mechanisms. Doxorubicin resistance in ovarian cancer highlights need for redox-targeted combinations (Özdemır et al., 2023). In vitro tumor models test drugs but poorly predict in vivo efficacy (Nunes, 2018).

Essential Papers

Effect of Thymoquinone on Ovarian Carcinoma Cell Viability (OVCAR-3)

İlhan Özdemır, Cenap Ekinci, Cenap Ekinci · 2023 · Journal of Drug Delivery and Therapeutics · 2 citations

Aim: Ovarian cancer is the third most common gynecological malignancy worldwide. However, it has the highest mortality rate among cancers due to its asymptomatic course, late diagnosis and recurren...

A REVIEW OF ROLE OF X-RAY DIFFRACTION IN STRUCTURAL ELUCIDATION OF BIOLOGICAL MOLECULES

Rabia Iqtadar, Saira Rehmat, Saira Asghar · 2023 · Hamdard Journal of Pharmacy · 1 citations

The importance of structural elucidation via X-ray diffraction (XRD) in drug discovery cannot be overstated. It plays a pivotal role in advancing drug development and design by providing valuable i...

In Vitro Characterization Of Serine 47 Phosphorylated Cytochrome C

Ashwathy Varughese · 2014 · DigitalCommons - WayneState (Wayne State University) · 0 citations

Cytochrome c is a 12.4kDa ubiquitously expressed protein known to be involved in many physiological processes of the cell such as respiration and apoptosis. The goal of our lab is to increase our k...

2013 METALS IN BIOLOGY GORDON RESEARCH CONFERENCE, JANUARY 20-25, 2013

Amy C. Rosenzweig · 2013 · 0 citations

Typical topics for lectures and posters include: biochemical and biophysical characterization of new metal containing proteins, enzymes, nucleic acids, factors, and chelators from all forms of life...

Modelo tumoral in vitro para a avaliação terapêutica de fármacos

Ana Raquel Santos Nunes · 2018 · UBibliorum repositorio digital da ubi (University of Beira Interior) · 0 citations

The anticancer therapies used nowadays in the clinic display a low efficacy. The ability of cancer cells to develop resistance to drugs used in chemotherapy, contributes to the high mortality assoc...

The Warburg Effect and its Role in Tumorigenesis

Angela Peddapalli · 2025 · Journal of Student Research · 0 citations

The second leading cause of death in the United States, cancer is the rapid proliferation of abnormal cells that grow and spread beyond their usual boundaries in the body. A significant part of can...

Reading Guide

Foundational Papers

Start with Varughese (2014) for cytochrome c phosphorylation in apoptosis and respiration; Rosenzweig (2013) for metals in redox biology enzymes.

Recent Advances

Özdemır et al. (2023) on thymoquinone-ROS in ovarian cancer; Peddapalli (2025) linking Warburg effect to redox tumorigenesis.

Core Methods

In vitro viability assays (OVCAR-3 cells); serine phosphorylation characterization; X-ray diffraction for structures; tumor model drug screening.

How PapersFlow Helps You Research Redox Signaling in Cancer Cells

Discover & Search

PapersFlow's Research Agent uses searchPapers and exaSearch to find ROS-cancer papers, revealing citationGraph connections from Varughese (2014) cytochrome c work to recent thymoquinone studies. findSimilarPapers expands to Warburg-redox links (Peddapalli, 2025).

Analyze & Verify

Analysis Agent applies readPaperContent to extract ROS mechanisms from Özdemır et al. (2023), then verifyResponse with CoVe checks claims against 250M+ corpus. runPythonAnalysis plots viability data from OVCAR-3 experiments; GRADE scores evidence strength for cytochrome c phosphorylation (Varughese, 2014).

Synthesize & Write

Synthesis Agent detects gaps in redox-apoptosis links across papers, flagging contradictions in ROS roles. Writing Agent uses latexEditText and latexSyncCitations to draft reviews citing Varughese (2014), with latexCompile for publication-ready output and exportMermaid for signaling pathway diagrams.

Use Cases

"Analyze OVCAR-3 viability data from thymoquinone vs doxorubicin papers"

Research Agent → searchPapers('thymoquinone OVCAR-3') → Analysis Agent → readPaperContent(Özdemır 2023) → runPythonAnalysis (NumPy/pandas dose-response curves) → matplotlib viability plots.

"Draft LaTeX review on cytochrome c redox in cancer apoptosis"

Synthesis Agent → gap detection (cytochrome c papers) → Writing Agent → latexEditText (intro/methods) → latexSyncCitations (Varughese 2014) → latexCompile (full PDF review).

"Find code for ROS simulation in tumor models"

Research Agent → searchPapers('ROS signaling cancer simulation') → Code Discovery → paperExtractUrls → paperFindGithubRepo → githubRepoInspect (Python redox models).

Automated Workflows

Deep Research workflow scans 50+ redox-cancer papers via searchPapers → citationGraph → structured report on ROS pathways (Özdemır et al., 2023). DeepScan applies 7-step CoVe analysis to verify cytochrome c claims (Varughese, 2014). Theorizer generates hypotheses linking metals to redox signaling from conference topics (Rosenzweig, 2013).

Try Doxa for Redox Signaling in Cancer Cells Research

Frequently Asked Questions

What defines redox signaling in cancer cells?

Redox signaling involves ROS regulating pathways for proliferation, apoptosis, and metastasis via thiol modifications on proteins like cytochrome c (Varughese, 2014).

What methods study redox in cancer?

In vitro assays test viability (Özdemır et al., 2023); X-ray diffraction elucidates protein structures (Iqtadar et al., 2023); phosphorylation analysis characterizes cytochrome c (Varughese, 2014).

What are key papers on this topic?

Foundational: Varughese (2014) on serine 47 phosphorylated cytochrome c; Rosenzweig (2013) on metals in biology. Recent: Özdemır et al. (2023) on thymoquinone in ovarian cancer.

What open problems exist?

Challenges include in vivo ROS quantification, selective therapy translation without normal cell damage, and full mapping of redox-protein interactions (Nunes, 2018; Peddapalli, 2025).